Renaissance Technologies (RenTech)'s ABEO Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 161,082 shares of Abeona Therapeutics Inc. (ABEO) worth $721,647, representing 0.00% of the portfolio. First purchased in 2020-Q1, this long-term strategic position has been held for 25 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in ABEO, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2024, adding 429,456 shares. Largest reduction occurred in Q4 2025, reducing 410,237 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Abeona Therapeutics (ABEO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Abeona Therapeutics (ABEO) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +44,882 | Add 38.62% | 161,082 | $4.48 |
| Q4 2025 | -410,237 | Reduce 77.93% | 116,200 | $5.27 |
| Q3 2025 | +226,500 | Add 75.52% | 526,437 | $5.28 |
| Q2 2025 | +168,400 | Add 128.02% | 299,937 | $5.68 |
| Q1 2025 | +42,300 | Add 47.40% | 131,537 | $4.76 |
| Q4 2024 | -45,041 | Reduce 33.54% | 89,237 | $5.57 |
| Q3 2024 | -369,015 | Reduce 73.32% | 134,278 | $6.32 |
| Q2 2024 | +429,456 | Add 581.63% | 503,293 | $4.24 |
| Q1 2024 | -108,556 | Reduce 59.52% | 73,837 | $7.25 |
| Q4 2023 | +151,556 | Add 491.47% | 182,393 | $5.01 |
| Q3 2023 | -2,700 | Reduce 8.05% | 30,837 | $4.22 |
| Q2 2023 | -3,300 | Reduce 8.96% | 33,537 | $0.00 |
| Q1 2023 | -25,800 | Reduce 41.19% | 36,837 | $0.00 |
| Q4 2022 | -5,500 | Reduce 8.07% | 62,637 | $0.00 |
| Q3 2022 | -27,790 | Reduce 28.97% | 68,137 | $3.04 |
| Q2 2022 | +2,894 | Add 3.11% | 95,927 | $5.20 |
| Q1 2022 | +5,928 | Add 6.81% | 93,033 | $7.88 |
| Q4 2021 | +85,125 | Add 4299.24% | 87,105 | $8.43 |
| Q3 2021 | +1,980 | New Buy | 1,980 | $27.78 |
| Q2 2021 | -20,891 | Sold Out | 0 | $0.00 |
| Q1 2021 | -32,025 | Reduce 60.52% | 20,891 | $47.01 |
| Q4 2020 | +45,706 | Add 633.93% | 52,916 | $39.25 |
| Q3 2020 | -131 | Reduce 1.78% | 7,210 | $25.52 |
| Q2 2020 | +4,332 | Add 143.97% | 7,341 | $72.88 |
| Q1 2020 | +3,009 | New Buy | 3,009 | $52.51 |
Renaissance Technologies (RenTech)'s Abeona Therapeutics Investment FAQs
Renaissance Technologies (RenTech) first purchased Abeona Therapeutics Inc. (ABEO) in Q1 2020, acquiring 3,009 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Abeona Therapeutics Inc. (ABEO) for 25 quarters since Q1 2020.
Renaissance Technologies (RenTech)'s largest addition to Abeona Therapeutics Inc. (ABEO) was in Q2 2024, adding 503,293 shares worth $2.13 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 161,082 shares of Abeona Therapeutics Inc. (ABEO), valued at approximately $721,647.
As of the Q1 2026 filing, Abeona Therapeutics Inc. (ABEO) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Abeona Therapeutics Inc. (ABEO) was 526,437 shares, as reported at the end of Q3 2025.